How to Buy Replimune Group Stock
Replimune Group Inc
Replimune Group, Inc. , a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer.
Replimune Group stock last closed at $7.60, up 8.11% from the previous day, and has decreased 25.64% in one year. It has overperformed other stocks in the Biotechnology industry by 0.4 percentage points. Replimune Group stock is currently +183.58% from its 52-week low of $2.68, and -55.29% from its 52-week high of $17.00.
There are currently 77.09M REPL shares outstanding. The market capitalization of REPL is $585.86M. In the last 24 hours, 9.77M REPL shares were traded.
How to Buy Replimune Group Stock
Wondering how to invest in Replimune Group stock? Here's how.
- Decide where to buy Replimune Group stock: You need to decide on a stock brokerage, but don't worry - we've sifted through dozens of stock brokerages and apps to help you decide where to buy Replimune Group stock.
- Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Put funds into your investment account: Select your method of payment and add your details.
- Analyze Replimune Group stock: The Replimune Group ticker symbol is REPL. Is Replimune Group stock a good investment? Should you buy shares of REPL? How do REPL's underlying business fundamentals look? Do top analysts think Replimune Group is a good buy? Why has REPL's stock price moved recently? (Hint: Our stock analysis website can help you decide if REPL is a good stock to buy).
- Make your REPL trade: Decide if you will purchase REPL shares at the current market price or use a limit order to purchase REPL shares at a particular price.
- Track your investment in REPL: Create a watchlist to get the latest news on your investment in Replimune Group shares.
Step 1: Decide where to buy Replimune Group stock
You will need an online brokerage account in order to access the NASDAQ market and buy REPL shares.
Our preferred brokerage: eToro
In our opinion, eToro is the best online stock brokerage. Here's why:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to world markets: From Technology to Utilities, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro boasts a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Create a brokerage account
Now that you've chosen your brokerage, the next step is to fill out some personal details so you are able to buy REPL stock today.
How to Create a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal info to create your new trading account.
- Submit your information by clicking the "Create Account" button. Get started with eToro today
Step 3: Put funds into your investment account
Now that you've finished signing up on a mobile trading app, you can securely and quickly fund your account:
Watch the video below for more details depositing funds into your new investment account.
Step 4: Analyze Replimune Group stock
Once you have selected the best place to buy Replimune Group stock, it's critical to research their stock prior to investing, so you truly wrap your head around the risk as well as the opportunity.
Replimune Group shares data
Replimune Group Due Diligence Checks
WallStreetZen was created to help average investors perform better fundamental analysis.
You can see all of the due diligence checks on REPL's stock page.
What is the fair value of REPL stock?
You can use many financial metrics, analyses, models, and charts to gauge REPL's true value.
Using relative valuations ratios:
- REPL could be undervalued based on its P/B ratio of 1.41x, relative to Biotechnology industry P/B ratio of 4.3x
You can do additional valuation research on REPL's stock here.
REPL Financial Health
Passed Health Checks:
- REPL has $485.51M in cash and short term investments. This is enough to cover its annual cash burn of $198.94M.
- REPL has cash burn of 198937000. It has enough cash and short-term investments to cover this for at least one year.
- There are more short-term assets than short-term liabilities on the REPL balance sheet.
- There are more short-term assets than long-term liabilities on the REPL balance sheet.
- REPL has a low debt to equity ratio of 0.33.
Failed Health Checks:
- Total REPL debt is higher than 5 years ago, relative to shareholder equity.
Is REPL stock a Buy, Hold, or Sell, according to analysts?
Out of 8 sell side analysts who research REPL, the consensus analyst rating on Replimune Group is a Buy
Please keep in mind that analyst ratings are not recommendations, nor are they investment advice.
Latest REPL Analyst Recommendations
Robert Driscoll, a top 22% analyst from Wedbush downgrades REPL to a hold rating and lowers their REPL price target from $19.00 to $4.00, on Jul 22, 2025.
Robert Burns, a bottom 1% analyst from HC Wainwright & Co. reiterates REPL with a buy rating and maintains their REPL price target from $22.00 to $22.00, on Jul 3, 2025.
Allison Bratzel, a top 11% analyst from Piper Sandler maintains REPL with a strong buy rating and raises their REPL price target from $14.00 to $22.00, on Jun 2, 2025.
Piper Sandler's Allison Bratzel raised their price target on Replimune Group (NASDAQ: REPL) by 57.1% from $14 to $22 on 2025/06/02. The analyst maintained their Strong Buy rating on the stock.
Replimune Group reported its Q4 and FY 2025 earnings on 2025/05/22.
Hiking their price target, Bratzel made the following points:
- Piper Sandler raised its RP1 revenue estimates following (1) the print, (2) disclosure of additional RP1 data at ASCO, (3) its hosting of a melanoma key opinion leader event, and (4) its hosting of investor meetings with Replimune Group management last week.
- With its Priority Review status, RP1 has a 2025/07/ 22 PDUFA date, which remains on track, with the FDA explicitly indicating that an AdCom is not expected.
- Although there is no such thing as a completely de-risked BLA, Piper Sandler continues to believe that investor skepticism around RP1 approvability is overdone.
- Their firm "likes" the company's commercial preparedness and has revised its market build to better reflect expected market dynamics and pricing.
All in all, the stock offers "a very favorable risk/reward heading into the PDUFA," the analyst told readers.
You can dive deeper into what analysts are projecting on the Replimune Group stock forecast page.
REPL Trading Indicators
Are REPL executives and large shareholders buying or selling the stock?
Over the past year, insiders at REPL have sold more shares than they have bought.
Philip Astleysparke, Director of REPL, was the latest REPL insider to sell. They sold $260,168.74 worth of REPL stock on May 20, 2025.
Learn more about who owns REPL stock here.
Does REPL stock generate passive income?
No, Replimune Group doesn't provide an income stream by paying out dividends.
REPL Social Trading Data
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Make your REPL trade
There are two primary order types:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are usually the easiest way to buy. - Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
If you want to make sure you're buying or selling at a particular dollar amount limit, use a limit order.
Hit the Open button and your broker will place your order.
If you want more help buying stocks on eToro, click the helpful video below:
Step 6: Track your investment in REPL
Now that you own some REPL stock, you'll want to keep up with your company.
Create a watchlist to track the latest developments regarding your REPL stock.
REPL Feed
How to Buy Stock in Replimune Group
To reiterate, here are the 6 steps to buy stock in Replimune Group:
- Decide where to buy Replimune Group stock
- Create a brokerage account
- Put funds into your investment account
- Analyze Replimune Group stock
- Make your REPL trade
- Track your investment in REPL
If you require a online brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you want to monitor your new investment in Replimune Group, click the button below.
More Content You Might Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.